🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Ann Marie Egloff

Brigham and Women's Hospital

ORCID: 0000-0002-1182-2793

Also affiliated with Harvard University, Dana-Farber Cancer Institute

Immunology and MicrobiologyBiochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 14 papers. Top paper: “Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus–Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial”.

Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus–Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-1695

N/A

7.0DataRank · unranked

368 citations

Katie M. Campbell, Ann Marie Egloff, Paul Zolkind, Zachary L. Skidmore, Brian Nussenbaum +39 more

Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker

Cancer Discovery(2023)10.1158/2159-8290.cd-23-0313

N/A

1.7DataRank · unranked

85 citations

Connie Wu, Peter C. Fridy, Stephanie J. Zhang, Yasmeen Senussi, Justina C. Wolters +54 more

The Mutational Landscape of Head and Neck Squamous Cell Carcinoma

Science(2011)10.1126/science.1208130

N/A

1.2DataRank · unranked

2533 citations

Ann Marie Egloff, Aaron D. Tward, Aleksandar D. Kostic, Kristian Cibulskis, Sachet A. Shukla +38 more

Yap1 Mediates Trametinib Resistance in Head and Neck Squamous Cell Carcinomas

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-19-4179

N/A

0DataRank · unranked

41 citations

Katie M. Campbell, Jason A. Webb, Paul Zolkind, Zachary L. Skidmore, Rachel Riley +10 more

The mouse oral carcinoma (MOC) model: A 10-year retrospective on model development and head and neck cancer investigations

Oral Oncology(2022)10.1016/j.oraloncology.2022.106012

N/A

0DataRank · unranked

43 citations

Shin Saito, Ann Marie Egloff, Clint Allen, Ravindra Uppaluri, Michihisa Kono

503 Cytotoxic revival is implicated in response to neoadjuvant PD-1 blockade for head and neck squamous cell carcinoma

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.0503

N/A

0DataRank · unranked

2 citations

Giacomo Oliveira, Ann Marie Egloff, Zexiang Zeng, Rebecca D. Chernock, Liye Zhou +33 more

Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti–PD-1 in head and neck cancer

Science Immunology(2023)10.1126/sciimmunol.adf4968

N/A

0DataRank · unranked

118 citations

Ann Marie Egloff, Alexander B. Afeyan, Jacquelyn O. Wolff, Zexiang Zeng, Rebecca D. Chernock +34 more

Circulating tumor-tissue modified HPV DNA testing in the clinical evaluation of patients at risk for HPV-positive oropharynx cancer: The IDEA-HPV study

Oral Oncology(2023)10.1016/j.oraloncology.2023.106584

N/A

0DataRank · unranked

17 citations

Rosh K.V. Sethi, Annette Wang, Kirsten F. A. A. Dabekaussen, Ann Marie Egloff, Catherine Del Vecchio Fitz +5 more

Identification of HPV16 E1 and E2-specific T cells in the oropharyngeal cancer tumor microenvironment

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-006721

N/A

0DataRank · unranked

10 citations

Shilpa Bhatia, Brinda Vijaykumar, Qiaomu Tian, Yanbo Sun, Del Leistritz-Edwards +8 more

Targeting Dendritic Cell Dysfunction to Circumvent Anti-PD1 Resistance in Head and Neck Cancer

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3477

N/A

0DataRank · unranked

15 citations

Michihisa Kono, Hoang C.B. Nguyen, Ann Marie Egloff, Cameron Messier, Patrick H. Lizotte +4 more

Enhanced oral versus flank lymph node T cell response parallels anti-PD1 efficacy in head and neck cancer

Oral Oncology(2024)10.1016/j.oraloncology.2024.106795

N/A

0DataRank · unranked

6 citations

Shin Saito, Masahiro Rokugo, Ann Marie Egloff, Ravindra Uppaluri, Michihisa Kono

IDENTIFICATION OF MUC1-C AS A TARGET FOR SUPPRESSING PROGRESSION OF HEAD AND NECK SQUAMOUS CELL CARCINOMAS

Cancer Research Communications(2024)10.1158/2767-9764.crc-24-0011

N/A

0DataRank · unranked

5 citations

Naoki Haratake, Atrayee Bhattacharya, Weipu Mao, Kangjie Xu, Keyi Wang +13 more

Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase 2 Trial

medRxiv(2020)10.1101/2020.03.18.20037846

N/A

0DataRank · unranked

4 citations

Katie M. Campbell, Ann Marie Egloff, Paul Zolkind, Zachary L. Skidmore, Brian Nussenbaum +39 more

Multi-tiered genomic analysis of head and neck cancer ties TP53 mutation to 3p loss

UNC Libraries(2020)10.17615/seks-5275

N/A

0DataRank · unranked

0 citations

Scott M. Lippman, Ezra E.W. Cohen, Trey Ideker, Ann Marie Egloff, John Paul Shen +8 more